Targeting Histone Deacetylases as a Multifaceted Approach to Treat the Diverse Outcomes of Stroke
- 1 August 2009
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Stroke
- Vol. 40 (8), 2899-2905
- https://doi.org/10.1161/strokeaha.108.540229
Abstract
Achieving therapeutic efficacy in ischemic stroke represents one of the biggest challenges in translational neurobiology. Despite extensive efforts, tissue plasminogen activator remains the only available intervention for enhancing functional recovery in humans once a stroke has occurred. To expand the repertoire of therapeutic options in stroke, one must consider and target its diverse pathophysiologies that trigger cell loss in a manner that also permits and enhances neuronal plasticity and repair. Several converging lines of inquiry suggest that histone deacetylase (HDAC) inhibition could be a strategy to achieve these goals. Here, we review evidence that targeting HDACs with low-molecular-weight inhibitors significantly decreases neuronal injury and improves functional outcome in multiple preclinical models of focal ischemia. These salutary effects emanate, in part, from modifications of chromatin and nonchromatin proteins that enhance adaptive gene expression or adaptive protein function. Together, the findings suggest that HDAC inhibition is a strategy capable of targeting diverse pathophysiologies of stroke with a wide therapeutic window.Keywords
This publication has 40 references indexed in Scilit:
- Neuroprotection for ischemic stroke: Past, present and futureNeuropharmacology, 2008
- StrokeThe Lancet, 2008
- Pulse Inhibition of Histone Deacetylases Induces Complete Resistance to Oxidative Death in Cortical Neurons without Toxicity and Reveals a Role for Cytoplasmic p21waf1/cip1in Cell Cycle-Independent NeuroprotectionJournal of Neuroscience, 2008
- Histone Deacetylase Inhibitors Exhibit Anti-Inflammatory and Neuroprotective Effects in a Rat Permanent Ischemic Model of Stroke: Multiple Mechanisms of ActionThe Journal of pharmacology and experimental therapeutics, 2007
- Pharmacological Inhibition of Histone Deacetylases by Suberoylanilide Hydroxamic Acid Specifically Alters Gene Expression and Reduces Ischemic Injury in the Mouse BrainMolecular Pharmacology, 2006
- Translation of Ischemic Preconditioning to the PatientStroke, 2004
- Sodium 4-Phenylbutyrate Protects against Cerebral Ischemic InjuryMolecular Pharmacology, 2004
- Valproic acid reduces brain damage induced by transient focal cerebral ischemia in rats: potential roles of histone deacetylase inhibition and heat shock protein inductionJournal of Neurochemistry, 2004
- Pathophysiology of Focal Cerebral Ischemia: a Therapeutic PerspectiveJournal of Vascular and Interventional Radiology, 2004
- DNA Methyltransferase Contributes to Delayed Ischemic Brain InjuryJournal of Neuroscience, 2000